Stock Updates

How has Thermo Fisher Scientific, Inc.:(NYSE:TMO) performed recently?

Thermo Fisher Scientific, Inc. (NYSE: TMO) is a large market cap stock with a market cap of 62346.49. It is in the Medical Laboratories & Research industry and sector Healthcare, with a current P/E of 31.62, a forward P/E of 17.07 and EPS of 5.01. At a stock price of 158.28 (0.45%) it has a dividend yield of 0.38%.

EPS growth for the last five years have been 15.00%, more recently this last year it has grown by 4.60%. The next year growth is going to be about 13.45% and more long-term 10.83% after five years. EPS growth quarter over quarter is 2.20%. Sales growth for the past five years have been 10.30% and sales growth quarter over quarter is 6.20%.

For performance, Thermo Fisher Scientific, Inc. the past week has seen a gain of -0.23%. For the last month performance for Thermo Fisher Scientific, Inc. is 4.93%. While the last quarter is 6.29% and half year, 11.65%. Finally for the year, performance is 28.09%.

The 52-week high for Thermo Fisher Scientific, Inc., is at -1.39%, and for the 52-week low it comes to a value of 32.59%. The 20-day simple moving average is 2.67% and 9.12% for the 200-day simple moving average.

Volatility for the week is at 1.60%, and for the month it is 1.59%. Thermo Fisher Scientific, Inc., has a target price of 173.29.

In terms of debt, long term debt/equity is 0.55, and for total debt/equity Thermo Fisher Scientific, Inc. has 0.67. The gross margin is 45.60%, while operating margin is *TBA, the profit margin is *TBA. The current ratio is 1.1 and the quick ratio is 0.8.

Insider ownership is at 0.20%, with instituitional ownership at 89.40%. Thermo Fisher Scientific, Inc. has a payout ratio of *TBA. With the total shares outstanding coming to 393.9. The shares float is 393.72, with the float short at 1.31%, with short ratio coming to 3.81.

In terms of returns, the return on assets see Thermo Fisher Scientific, Inc., get *TBA, with its returns on investment at 7.00%. Return on equity is *TBA. So will the investors see the target price of 173.29, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment